XPH ETF top 10 holdings are 21.7% of the fund as of Jun 30, 2026

XPH ETF top 10 holdings are 21.7% of the fund as of Jun 30, 2026
$72.80
See how much of XPH you already own
Just $25 once·$69/mo·Download sample
X-ray my portfolio free

XPH holds 21.7% of its assets in its 10 largest positions as of Jun 30, 2026. XPH is State Street SPDR S&P Pharmaceuticals ETF.

Showing the top 10 of 67 holdings · as of Jun 30, 2026
Top 10 weight
21.70%
XPH top 10 holdings, by weight
#TickerNameWeightCumulativeSharesSectorIndustry
1Definium Therapeutics, Inc. Common Shares
2.88%
2.9%290,045--
2
MBX
Mbx Biosciences IncHealth Care · Biotechnology
2.81%
5.7%217,506Health CareBiotechnology
Share changes, sector and industry · Pro
3
ALMS
Alumis Inc
2.05%
7.7%336,026
4
ELVN
Enliven Therapeutics Inc
2.04%
9.8%182,178
5
TRVI
Trevi Therapeutics Inc.
2.02%
11.8%503,029
6
AMLX
Amylyx Pharmaceuticals Inc
2.01%
13.8%500,791
7
MAZE
Maze Therapeutics Inc
1.98%
15.8%274,078
8
MANE
Veradermics Inc
1.98%
17.8%72,490
9Ataibeckley Inc.
1.98%
19.8%1,783,234
10
LGND
Ligand Pharmaceuticals, Inc.
1.95%
21.7%27,150
More holdings · Pro
FundXLS Pro
See the other 57 holdings of XPH
X-ray every fund you own at once, ETFs and mutual funds that hold stocks directly, and see how much of your money lands on the same stocks twice.
Unlock FundXLS Pro$45/quarter Pro · Cancel anytime
Themes in the top 10
BiotechnologyPharmaceuticalsLife Sciences ToolsBiotechnology ToolsOncologyData & AnalyticsEmerging TechImmunology

XPH ETF Top Holdings

XPH holdings top 10 positions. The top 10 holdings account for 21.7% of the fund, led by Definium Therapeutics, Inc. Common Shares at 2.9%, Mbx Biosciences Inc at 2.8%, Alumis Inc Common Stock USD 0.0001 at 2.0%.

XPH portfolio concentration is well-diversified, with the top 10 representing 21.7% of total assets. The largest sector exposure is Health Care at 84.1%.

XPH sectors provide a detailed breakdown. XPH overlap shows how holdings compare to other funds in your portfolio.

Showing 10 of 67 holdingsTop 10 Weight: 21.70%
#TickerNameIndustryWeightAllocation
1DFTX:CADefinium Therapeutics, Inc. Common SharesUnknown2.88%
2MBXMbx Biosciences IncHealth Care2.81%
3ALMSAlumis Inc Common Stock USD 0.0001Industrials2.05%
4ELVNEnliven Therapeutics IncHealth Care2.04%
5TRVITrevi Therapeutics Inc.Health Care2.02%
6AMLXAmylyx Pharmaceuticals IncHealth Care2.01%
7MAZEMaze Therapeutics IncHealth Care1.98%
8MANEVeradermics IncUnknown1.98%
9ATAIAtaibeckley Inc.Health Care1.98%
10LGNDLigand Pharmaceuticals, Inc.Health Care1.95%
Want to see all 67 holdings?

Holdings Distribution

Loading chart...